OncoResponse

OncoResponse

OncoResponse

OncoResponse is a company providing cancer research into immunotherapies and the newest technologies for oncologists.
Type
B2c
Founded
2015
Raised
$50M
Follow us
Alexa global traffic share
Latest funding Show all
$40,000,000
Venture capital (Series B) - 2018
Canaan Partners Redmile Group ARCH Venture Partners +6
$3,000,000
Venture capital (Series A) - 2017
Team Size
1–10
Employees
GeekWire

Seattle biotech OncoResponse raises $40.6M to create antibody-based treatments for cancer

$40,000,000 Venture capital (Series B)
FinSMEs , PE HUB , Xconomy , +1

OncoResponse Raises $40M in Series B Financing

Funding Health